Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Q&A: Anat Loewenstein on the Ramin Tadayoni Award | Ophthalmology Times
Photo of Anat Loewenstein, MD, who served as the 2025 EURETINA president The Ramin Tadayoni Award is an initiative by the EURETINA board and Oculis company to honor the late Professor Ramin Tadayoni and support promising retinal research. This year,…
New study links rising myopia rates in China to environmental factors | Ophthalmology Times
A new epidemiology study published in the British Journal of Ophthalmology reported that the prevalence rates and severity of myopia have seen major increases between generations because of increased axial elongation in the children. The investigators, led by first author…
Study finds no change in smooth pursuit eye movement velocity after 1 season of college football | Ophthalmology Times
A study of the effects of repetitive impacts to the head during one season of football found that the smooth pursuit velocity was unaffected in American college football players,1 reported first study author Nicholas G. Murray, PhD, from the Department…
Q&A: Daniela Bacherini discusses using ultra widefield OCT to evaluate peripheral retinal degenerations | Ophthalmology Times
Photo of Daniela Bacherini at the 2025 EURETINA meeting Daniela Bacherini, MD, PhD, FEBO, from the University of Florence presented at the EURETINA 2025 meeting, focusing on ultra widefield peripheral OCT imaging of retinal degenerations. She explored how this advanced…
Looking ahead: Ophthalmologists envision a world without the toughest diseases | Ophthalmology Times
As Ophthalmology Times celebrates its 50th anniversary, we took the opportunity to ask a thought-provoking question to some of the field’s leading experts: “In a perfect world, if you could cure one eye disease or condition with the snap of…
Q&A: Boris Stanzel on the use of methotrexate in PVR cases | Ophthalmology Times
Photo of Boris Stanzel, MD, at the 2025 EURETINA meeting Professor Boris Stanzel, MD, presented research on methotrexate’s use in PVR retinal detachment surgery at the 2025 EURETINA congress, which was held in Paris, France. The study of 20 patients…
Increased complications in cataract surgery during the COVID-19 pandemic | Ophthalmology Times
(Image credit: AdobeStock/phonlamaiphoto) Canadian researchers recently reported significant increases in complications during cataract surgeries performed during the COVID-19 pandemic compared with the pre-pandemic period.1 First author Nathan Lee-Wing, BS, and MD candidate at the Max Rady College of Medicine, University…
FDA approves abbreviated new drug application from Amneal Pharmaceuticals for bimatoprost ophthalmic solution 0.01% | Ophthalmology Times
(Image Credit: AdobeStock) The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ Abbreviated New Drug Application (ANDA) for bimatoprost ophthalmic solution 0.01% (2.5 mL, 5 mL and 7.5 mL).1 An ANDA is a submission to the FDA that…
The European Commission grants marketing authorization for EYLUXVI | Ophthalmology Times
(Image Credit: AdobeStock) The European Commission (EC) has granted marketing authorization for EYLUXVI (ALT-L9), an aflibercept (Eylea) biosimilar from Alteogen, co-developed by its subsidiary, Alteogen Biologics.1 EYLUXVI is Alteogen’s second approved biosimilar; the other approval is the company’s trastuzumab (Herceptin) biosimilar. Alteogen received a…
Luxa Biotechnology announces clinical trial results for treatment of AMD | Ophthalmology Times
(Image credit: ©Alex_Traksel/AdobeStock) Luxa Biotechnology LLC announced results from its phase 1/2a clinical trial titled “Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Transplantation in Patients with Dry Age-related Macular Degeneration: Low Dose Clinical Outcomes.”1 The results were published…